webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

PC-Biotin-PEG4-PEG3-azide

  CAS No.: 2055198-04-2   Cat No.: BADC-01050   Purity: >98.0% 4.5  

PC-Biotin-PEG4-PEG3-azide is a multifunctional ADC linker combining biotin affinity, PEG spacers, and azide reactivity, enabling site-specific copper-free click chemistry conjugation and streamlined purification in ADC production.

PC-Biotin-PEG4-PEG3-azide

Structure of 2055198-04-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C39H63N9O14S
Molecular Weight
914.03
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
1-[5-[[3-[2-[2-[2-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]methyl]-2-nitrophenyl]ethyl N-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl]carbamate
Canonical SMILES
CC(C1=C(C=CC(=C1)CNC(=O)CCOCCOCCOCCOCCNC(=O)CCCCC2C3C(CS2)NC(=O)N3)[N+](=O)[O-])OC(=O)NCCOCCOCCOCCN=[N+]=[N-]
InChI
InChI=1S/C39H63N9O14S/c1-29(62-39(52)42-10-14-57-18-22-60-23-19-58-15-11-44-47-40)31-26-30(6-7-33(31)48(53)54)27-43-36(50)8-12-55-16-20-59-24-25-61-21-17-56-13-9-41-35(49)5-3-2-4-34-37-32(28-63-34)45-38(51)46-37/h6-7,26,29,32,34,37H,2-5,8-25,27-28H2,1H3,(H,41,49)(H,42,52)(H,43,50)(H2,45,46,51)/t29?,32-,34-,37-/m0/s1
InChIKey
APXHNGAQDHMBFB-OITTVKJVSA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Form
Solid

PC-Biotin-PEG4-PEG3-azide is an advanced ADC linker intermediate designed for targeted antibody-drug conjugate (ADC) construction and precise bioconjugation applications. It combines a photoreactive (PC) group, biotin functionality, PEG4-PEG3 spacers, and a terminal azide, enabling dual conjugation strategies through photo-crosslinking and click chemistry. The PEG4-PEG3 spacers provide flexibility, reduce steric hindrance, and improve solubility of ADC payloads. In ADC linker design, PC-Biotin-PEG4-PEG3-azide supports site-specific attachment of cytotoxic payloads while preserving antibody stability and biological activity, allowing controlled intracellular delivery in tumor-targeted therapies.

In payload conjugation applications, PC-Biotin-PEG4-PEG3-azide is compatible with a broad spectrum of ADC cytotoxins, including microtubule inhibitors, DNA-targeting agents, and other potent therapeutic molecules. The photoreactive group enables covalent crosslinking upon UV activation, while the azide functionality allows bioorthogonal click chemistry for modular payload attachment. The biotin moiety provides additional utility for purification or detection. Together, the PEG4-PEG3 spacers enhance solubility, reduce aggregation, and facilitate homogeneous ADC construction, ensuring reproducible conjugation and optimized pharmacokinetics.

From an application perspective, PC-Biotin-PEG4-PEG3-azide is widely used in oncology-focused ADC research, protein bioconjugation studies, and multifunctional targeted drug delivery systems. Its combination of photoreactive chemistry, biotin labeling, and flexible PEG spacers enables precise, site-specific conjugation while maintaining antibody integrity. Leveraging this linker in ADC design allows researchers to create customizable, dual-functional linker-payload conjugates capable of efficient tumor targeting and selective intracellular payload release, tailored for complex therapeutic strategies.

What is PC-Biotin-PEG4-PEG3-azide used for in ADC development?

PC-Biotin-PEG4-PEG3-azide is a multifunctional linker combining a photocleavable biotin moiety with PEG spacers and an azide functional group. It allows photo-triggered release and bioorthogonal conjugation of payloads to antibodies for controlled studies.

29/9/2017

We would like to know how PC-Biotin-PEG4-PEG3-azide facilitates controlled release in ADCs.

The photocleavable group can be activated by specific wavelengths of light, enabling spatial and temporal control over payload release. This feature is valuable for mechanistic studies and targeted therapy applications.

19/6/2022

Could you kindly advise what conjugation strategies are compatible with PC-Biotin-PEG4-PEG3-azide?

The azide functional group allows for copper-free click chemistry with DBCO-modified antibodies, while the PEG4-PEG3 spacers improve solubility and reduce steric interference during conjugation.

29/8/2016

Good morning! Can PC-Biotin-PEG4-PEG3-azide be used in therapeutic ADCs?

Its primary use is in research and preclinical studies due to the photocleavable design. While in vivo therapeutic applications are possible, considerations regarding light penetration and stability must be addressed.

19/9/2020

Good morning! What analytical methods are recommended to confirm the integrity of PC-Biotin-PEG4-PEG3-azide?

The integrity of PC-Biotin-PEG4-PEG3-azide can be assessed using LC-MS or HPLC to confirm molecular identity and detect potential degradation products. UV-Vis spectroscopy may also be used to monitor the biotin moiety during storage and handling.

12/1/2023

— Dr. Robert Evans, Protein Chemist (USA)

PC-Biotin-PEG4-PEG3-azide linker enabled efficient biotinylation with minimal side reactions.

29/8/2016

— Prof. Elena Russo, Medicinal Chemist (Italy)

High-purity PC-Biotin-PEG4-PEG3-azide delivered by BOC Sciences facilitated downstream applications.

12/1/2023

— Dr. Stefan Weber, Bioconjugation Specialist (Germany)

The PEG4-PEG3 spacer improved solubility and flexibility, enhancing conjugation efficiency.

19/9/2020

— Ms. Laura Smith, R&D Manager (UK)

Excellent documentation and timely delivery accompanied this biotinylation linker.

29/9/2017

— Dr. Ingrid Jensen, ADC Project Lead (Denmark)

Using PC-Biotin-PEG4-PEG3-azide, we achieved consistent biotin labeling across multiple experiments.

— Mr. Felix Martin, Senior Scientist (France)

The linker’s quality and solubility enhanced our high-throughput conjugation workflow.

19/6/2022

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Boc-D-Lys(N3)-OH CHA salt | Boc-Dap-OH.DCHA | Fmoc-NH-ethyl-SS-propionic NHS ester | Telisotuzumab vedotin | INX-SM-56 | INX-SM-6 | Pyrrolobenzodiazepine (PBD) | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | Corixetan | N-(2-azidoacetyl)glycylglycine | PC-Biotin-PEG4-PEG3-azide
Send Inquiry
Verification code
Inquiry Basket